302 related articles for article (PubMed ID: 12545552)
1. Adeno-associated virus vectors for therapeutic gene transfer.
Stilwell JL; Samulski RJ
Biotechniques; 2003 Jan; 34(1):148-50, 152, 154 passim. PubMed ID: 12545552
[No Abstract] [Full Text] [Related]
2. Current development of adeno-associated viral vectors.
Romano G
Drug News Perspect; 2005 Jun; 18(5):311-6. PubMed ID: 16193103
[TBL] [Abstract][Full Text] [Related]
3. Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain.
Janson C; McPhee S; Bilaniuk L; Haselgrove J; Testaiuti M; Freese A; Wang DJ; Shera D; Hurh P; Rupin J; Saslow E; Goldfarb O; Goldberg M; Larijani G; Sharrar W; Liouterman L; Camp A; Kolodny E; Samulski J; Leone P
Hum Gene Ther; 2002 Jul; 13(11):1391-412. PubMed ID: 12162821
[TBL] [Abstract][Full Text] [Related]
4. Current and future prospects for hemophilia gene therapy.
Ward P; Walsh CE
Expert Rev Hematol; 2016 Jul; 9(7):649-59. PubMed ID: 27153210
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated virus vectors for gene therapy: more pros than cons?
Monahan PE; Samulski RJ
Mol Med Today; 2000 Nov; 6(11):433-40. PubMed ID: 11074369
[TBL] [Abstract][Full Text] [Related]
6. [Gene therapy of hemophilia].
Watzke HH
Internist (Berl); 2001 Oct; 42(10):1366-8, 1371-3. PubMed ID: 11688155
[No Abstract] [Full Text] [Related]
7. Targeted integration by adeno-associated virus.
Weitzman MD; Young SM; Cathomen T; Samulski RJ
Methods Mol Med; 2003; 76():201-19. PubMed ID: 12526165
[No Abstract] [Full Text] [Related]
8. Gene therapy for Canavan's disease takes a step forward.
Ahmed SS; Gao G
Mol Ther; 2013 Mar; 21(3):505-6. PubMed ID: 23449107
[No Abstract] [Full Text] [Related]
9. Harmful potential of viral vectors fuels doubts over gene therapy.
Check E
Nature; 2003 Jun; 423(6940):573-4. PubMed ID: 12789298
[No Abstract] [Full Text] [Related]
10. Vector integration and fate in the hemophilia dog liver multiple years after AAV-FVIII gene transfer.
Batty P; Fong S; Franco M; Sihn CR; Swystun LL; Afzal S; Harpell L; Hurlbut D; Pender A; Su C; Thomsen H; Wilson C; Youssar L; Winterborn A; Gil-Farina I; Lillicrap D
Blood; 2024 Jun; 143(23):2373-2385. PubMed ID: 38452208
[TBL] [Abstract][Full Text] [Related]
11. [Integration of AAV vectors and insertional mutagenesis].
Rossi A; Salvetti A
Med Sci (Paris); 2016 Feb; 32(2):167-74. PubMed ID: 26936174
[TBL] [Abstract][Full Text] [Related]
12. New approaches to gene and cell therapy for hemophilia.
Ohmori T; Mizukami H; Ozawa K; Sakata Y; Nishimura S
J Thromb Haemost; 2015 Jun; 13 Suppl 1():S133-42. PubMed ID: 26149014
[TBL] [Abstract][Full Text] [Related]
13. The gene therapy journey for hemophilia: are we there yet?
High KA
Hematology Am Soc Hematol Educ Program; 2012; 2012():375-81. PubMed ID: 23233607
[TBL] [Abstract][Full Text] [Related]
14. AAV viral vector delivery to the brain by shape-conforming MR-guided infusions.
Bankiewicz KS; Sudhakar V; Samaranch L; San Sebastian W; Bringas J; Forsayeth J
J Control Release; 2016 Oct; 240():434-442. PubMed ID: 26924352
[TBL] [Abstract][Full Text] [Related]
15. Adeno-associated virus vectors.
Carter BJ
Curr Opin Biotechnol; 1992 Oct; 3(5):533-9. PubMed ID: 1369403
[TBL] [Abstract][Full Text] [Related]
16. AAV-mediated gene therapy for hemophilia.
Couto LB; Pierce GF
Curr Opin Mol Ther; 2003 Oct; 5(5):517-23. PubMed ID: 14601521
[TBL] [Abstract][Full Text] [Related]
17. Adeno-associated virus vectors in clinical trials.
Carter BJ
Hum Gene Ther; 2005 May; 16(5):541-50. PubMed ID: 15916479
[No Abstract] [Full Text] [Related]
18. [Clinical application of gene therapy. Previous experience and the future].
Langer B; Cichutek K
Pharm Unserer Zeit; 2011 May; 40(3):254-62. PubMed ID: 21698615
[No Abstract] [Full Text] [Related]
19. Global CNS gene transfer for a childhood neurogenetic enzyme deficiency: Canavan disease.
Leone P; Janson CG; McPhee SJ; During MJ
Curr Opin Mol Ther; 1999 Aug; 1(4):487-92. PubMed ID: 11713764
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for Parkinson's disease: where are we now and where are we going?
Forsayeth J; Bankiewicz KS; Aminoff MJ
Expert Rev Neurother; 2010 Dec; 10(12):1839-45. PubMed ID: 21091315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
